192 related articles for article (PubMed ID: 18645709)
1. Association of the CYP17 gene polymorphism with risk for uterine leiomyoma in Brazilian women.
Vieira LC; Gomes MT; Castro Rde A; de Souza NC; da Silva ID; Baracat EC; Girão MJ
Gynecol Endocrinol; 2008 Jul; 24(7):373-7. PubMed ID: 18645709
[TBL] [Abstract][Full Text] [Related]
2. The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population.
Tsujino T; Ohara N; Yoshida S; Kennedy S; Takemura N; Deguchi M; Maruo T
Gynecol Endocrinol; 2006 Feb; 22(2):87-91. PubMed ID: 16603433
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma.
Villanova FE; Andrade PM; Otsuka AY; Gomes MT; Leal ES; Castro RA; Girão MJ; Nishimura E; Baracat EC; Silva ID
Steroids; 2006 Nov; 71(11-12):960-5. PubMed ID: 16935316
[TBL] [Abstract][Full Text] [Related]
4. No association of the 5' promoter region polymorphism of CYP17 gene with prostate cancer risk.
dos Santos A; Ribeiro ML; Mesquita JC; Carvalho-Salles AB; Hackel C
Prostate Cancer Prostatic Dis; 2002; 5(1):28-31. PubMed ID: 15195127
[TBL] [Abstract][Full Text] [Related]
5. A possible role of the cytochrome P450c17alpha gene (CYP17) polymorphism in the pathobiology of uterine leiomyomas from black South African women: a pilot study.
Amant F; Dorfling CM; de Brabanter J; Vandewalle J; Vergote I; Lindeque BG; van Rensburg EJ
Acta Obstet Gynecol Scand; 2004 Mar; 83(3):234-9. PubMed ID: 14995917
[TBL] [Abstract][Full Text] [Related]
6. Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?
El-Shennawy GA; Elbialy AA; Isamil AE; El Behery MM
Arch Gynecol Obstet; 2011 Jun; 283(6):1313-8. PubMed ID: 20559649
[TBL] [Abstract][Full Text] [Related]
7. The -2549 insertion/deletion polymorphism of VEGF gene associated with uterine leiomyoma susceptibility in women from Southeastern Iran.
Keshavarzi F; Salimi S; Mohammadpour-Gharehbagh A; Teimoori B; Yazdi A; Farajian-Mashhadi F; Yaghmaei M; Mokhtari M
Ginekol Pol; 2017; 88(3):115-119. PubMed ID: 28397198
[TBL] [Abstract][Full Text] [Related]
8. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.
Tüzüner BM; Oztürk T; Kisakesen HI; Ilvan S; Zerrin C; Oztürk O; Isbir T
In Vivo; 2010; 24(1):71-4. PubMed ID: 20133979
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in the CYP17 gene and recurrent spontaneous abortions.
Litridis I; Kapnoulas N; Natisvili T; Agiannitopoulos K; Peraki O; Ntostis P; Pantos K; Lamnissou K
Arch Gynecol Obstet; 2011 Feb; 283(2):289-93. PubMed ID: 20069306
[TBL] [Abstract][Full Text] [Related]
11. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.
Chakraborty A; Murthy NS; Chintamani C; Bhatnagar D; Mohil RS; Sharma PC; Saxena S
J Hum Genet; 2007; 52(2):159-165. PubMed ID: 17235448
[TBL] [Abstract][Full Text] [Related]
12. No association between estrogen receptor beta polymorphisms and uterine leiomyoma.
Zhai XD; Ye Y; Yang Y; Wang Z; Mo YN
DNA Cell Biol; 2009 Dec; 28(12):633-6. PubMed ID: 19715484
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of CYP17A1, CYP19, and androgen in Brazilian women with uterine leiomyomas.
Rosa FE; Canevari Rde A; Ambrosio EP; Ramos Cirilo PD; Pontes A; Rainho CA; Rogatto SR
Clin Chem Lab Med; 2008; 46(6):814-23. PubMed ID: 18601603
[TBL] [Abstract][Full Text] [Related]
14. Four novel single nucleotide polymorphisms within the promoter region of p53 gene and their associations with uterine leiomyoma.
Hsieh YY; Wang JP; Lin CS
Mol Reprod Dev; 2007 Jul; 74(7):815-20. PubMed ID: 17186536
[TBL] [Abstract][Full Text] [Related]
15. The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer.
Haiman CA; Stampfer MJ; Giovannucci E; Ma J; Decalo NE; Kantoff PW; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):743-8. PubMed ID: 11440959
[TBL] [Abstract][Full Text] [Related]
16. Combination effect of cytochrome P450 1A1 gene polymorphisms on uterine leiomyoma: A case-control study.
Salimi S; Sajadian M; Khodamian M; Yazdi A; Rezaee S; Mohammadpour-Gharehbagh A; Mokhtari M; Yaghmaie M
Bosn J Basic Med Sci; 2016 Aug; 16(3):209-14. PubMed ID: 27333216
[TBL] [Abstract][Full Text] [Related]
17. The role of MSP I CYP1A1 gene polymorphism in the development of uterine fibroids.
Barão MA; Oliveira E; Gomes MT; da Silva ID; Sartori MG; Girão MJ; Castro Rde A
Fertil Steril; 2010 Dec; 94(7):2783-5. PubMed ID: 20579990
[TBL] [Abstract][Full Text] [Related]
18. Two single nucleotide polymorphisms in the CYP17 and COMT Genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy. The Danish Osteoporosis Prevention Study.
Tofteng CL; Abrahamsen B; Jensen JE; Petersen S; Teilmann J; Kindmark A; Vestergaard P; Gram J; Langdahl BL; Mosekilde L
Calcif Tissue Int; 2004 Aug; 75(2):123-32. PubMed ID: 15129369
[TBL] [Abstract][Full Text] [Related]
19. CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
Verla-Tebit E; Wang-Gohrke S; Chang-Claude J
Breast Cancer Res; 2005; 7(4):R455-64. PubMed ID: 15987450
[TBL] [Abstract][Full Text] [Related]
20. The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population.
Onen IH; Ekmekci A; Eroglu M; Polat F; Biri H
DNA Cell Biol; 2007 Feb; 26(2):100-7. PubMed ID: 17328668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]